154 related articles for article (PubMed ID: 36327092)
1. DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.
Sun J; Wang X; Shen Q; Wang M; Chen S; Zhang X; Huang Y; Zhang Z; Li W; Yuan Y; Huang Z
Cell Oncol (Dordr); 2022 Dec; 45(6):1187-1202. PubMed ID: 36327092
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
[TBL] [Abstract][Full Text] [Related]
3. DNASE1L3 inhibits proliferation, invasion and metastasis of hepatocellular carcinoma by interacting with β-catenin to promote its ubiquitin degradation pathway.
Li B; Ge YZ; Yan WW; Gong B; Cao K; Zhao R; Li C; Zhang YW; Jiang YH; Zuo S
Cell Prolif; 2022 Sep; 55(9):e13273. PubMed ID: 35748106
[TBL] [Abstract][Full Text] [Related]
4. DNASE1L3 arrests tumor angiogenesis by impairing the senescence-associated secretory phenotype in response to stress.
Guo D; Ma D; Liu P; Lan J; Liu Z; Liu Q
Aging (Albany NY); 2021 Mar; 13(7):9874-9899. PubMed ID: 33744849
[TBL] [Abstract][Full Text] [Related]
5. MAPRE1 promotes cell cycle progression of hepatocellular carcinoma cells by interacting with CDK2.
Liang XH; Feng ZP; Liu FQ; Yan R; Yin LY; Shen H; Lu HL
Cell Biol Int; 2020 Nov; 44(11):2326-2333. PubMed ID: 32770827
[TBL] [Abstract][Full Text] [Related]
6. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
[TBL] [Abstract][Full Text] [Related]
7. YAP1-activated ZNF131 promotes hepatocellular carcinoma cell proliferation through transcriptional regulation of PAIP1.
Yin G; Jia S; Zhang Y; Xian Y; Guo Y; Liu Q
Arch Biochem Biophys; 2024 Apr; 754():109921. PubMed ID: 38341068
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).
Rajasekaran D; Jariwala N; Mendoza RG; Robertson CL; Akiel MA; Dozmorov M; Fisher PB; Sarkar D
J Biol Chem; 2016 May; 291(20):10736-46. PubMed ID: 26997225
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of IncRNA TPT1-AS1 Suppresses Hepatocellular Carcinoma Cell Proliferation by Downregulating CDK2.
Wei W; Huang X; Shen X; Lian J; Chen Y; Wang W; Huang J; Zhang B
Crit Rev Eukaryot Gene Expr; 2022; 32(1):1-9. PubMed ID: 35377976
[TBL] [Abstract][Full Text] [Related]
11. DNase1L3 suppresses hepatocellular carcinoma growth via inhibiting complement autocrine effect.
Chen QY; Li L; Suo DQ
Neoplasma; 2021 Jul; 68(4):683-691. PubMed ID: 33618518
[TBL] [Abstract][Full Text] [Related]
12. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
13. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
14. DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling.
Zhou H; Du Y; Wei X; Song C; Song J; Xu N; Huang W; Chen L; Yao F; Du D; Qiu C; Zhong L; Liu Y; Gu D; Wang J; Xu Y
Theranostics; 2022; 12(14):6069-6087. PubMed ID: 36168636
[No Abstract] [Full Text] [Related]
15. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
16. Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism.
Xiao Y; Yang K; Liu P; Ma D; Lei P; Liu Q
Int J Biol Sci; 2022; 18(1):82-95. PubMed ID: 34975319
[TBL] [Abstract][Full Text] [Related]
17. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
18. Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.
Huang S; Zhang C; Sun C; Hou Y; Zhang Y; Tam NL; Wang Z; Yu J; Huang B; Zhuang H; Zhou Z; Ma Z; Sun Z; He X; Zhou Q; Hou B; Wu L
Aging (Albany NY); 2020 Feb; 12(3):3025-3041. PubMed ID: 32045367
[TBL] [Abstract][Full Text] [Related]
19. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
20. Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth.
Lin WR; Lai MW; Yeh CT
Oncol Rep; 2013 Mar; 29(3):903-10. PubMed ID: 23292002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
